...BRCA2. Prevalent founder rearrangement mutations have been described in European populations. We sought to identify rear...
...BRCA2. mutations is being considered for Ashkenazi Jews (AJ) because 2.5% carry recurrent deleterious mutations and effe...
...BRCA2, in human cells synergistically reduces HR - indicating that RAD52 and BRCA2 control independent mechanisms of HR....
APRIN (PDS5 cohesin associated factor B) interacts with both the cohesin complex and the BRCA2 tumor suppressor. How APR...
...BRCA2. Other genes of lower penetrance are also known, explaining together up to 40% of the hereditary risk of breast ca...
...BRCA2 tumour suppressor gene mutations through synthetic lethality. However, PARP inhibition also shows considerable pro...
...BRCA2, NF1, and TP53 each. When assessing the clinical data, each of the 5 patients had one or more different types of c...
...BRCA2 mutations in Ashkenazi Jews (AJ) apparently fulfills screening criteria. We compared streamlined BRCA screening vi...
...BRCA2 (BRCA) mutations genomic loss of heterozygosity (LOH) might also represent homologous recombination deficiency. In...
...BRCA2 were most frequently mutated in CS. Grade 3 EC shares features of G1 tumor and Type II disease, most notably resem...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
